A. Ghirardello et al., BLOTTING PATTERNS OF IGG ANTI-(U1)RNP ANTIBODIES IN MIXED CONNECTIVE-TISSUE DISEASE, Rheumatology international, 16(4), 1996, pp. 145-150
Serum reactivities towards individual U1 snRNP proteins were determine
d by immunoblotting in 32 patients with mixed connective tissue diseas
e (MCTD). Time persistence of immunoblot profiles and clinical signifi
cance of anti-(U1)RNP antibody specificities were also investigated. I
gG anti-(U1)RNP antibodies were found in the sera of 29 out of 32 pati
ents (90.6%): 21 (65.6%) reacted with the 70-kD protein, 25 (78.1%) wi
th A, 23 (71.9%) with C and 20 (62.5%) with B/B' proteins. None were r
eactive with the Sm-D peptide. Seventy kilodalton antibody specificity
was strongly associated with a higher antinuclear antibody titre (>16
0) and slightly associated with disease activity; anti-B/B' specificit
y was associated with lymphadenopathy. Anti-A, -C and -B/B' antibodies
were negatively associated with systemic lupus erythematosus (SLE) sk
in rashes. Two types of anti-(U1)RNP blotting patterns were selected:
''full spectrum'' (53.1% of cases) and a ''partially/no reactive'' one
(46.9%). Such patterns were unchanged over time in 14 out of 16 cases
prospectively examined(87.5%), while the pattern shifted from ''full
spectrum'' to ''partially/no reactive'' in 2 cases (12.5%): in 1 after
a prolonged clinical remission (24 years) and in the other following
immunosuppressive therapy. The anti- (U1)RNP antibody immunoblot profi
le in MCTD patients consisted of various reactivities and remained unc
hanged over time in most cases. Antibody reactivity against the 70-kD
protein represented the major U1 snRNP specificity. The various anti-(
U1)RNP specific reactivities demonstrated poor clinical significance w
ithin MCTD. Thus, MCTD seems to be characterized by a longstanding ser
ological heterogeneity whose reactivities do not apparently correspond
to distinct features within the broad clinical spectrum of MCTD.